Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EC90 of alfentanil combined with 0.075% ropivacaine for epidural labor analgesia
ChiCTR2300067317Phase 4Not yet recruiting
- Sponsor
- General Hospital of the Northern Theater Command
- Start
- Jan 2023
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4, double-blind, single-arm trial of alfentanil and ropivacaine in labor pain, sponsored by General Hospital of the Northern Theater Command. Primary endpoint: Visual analog scale (VAS) pain score at 30 minutes after epidural analgesia. Planned start Jan 2023; status: not yet recruiting.
02
Drugs
alfentanilropivacaine
03
Conditions
labor pain
Beyond the preview
Go deeper on ChiCTR2300067317.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300067317.